| INSULET CORP. DL -,001 |
| USA |
| Gesundheit |
| US45784P1012 / A0MQX8 |
| GOV (Frankfurt) / PODD (NASDAQ) |
| FRA:GOV, ETR:GOV, GOV:GR, NASDAQ:PODD |
| - |
| https://www.insulet.com/ |
|
Insulet Corporation is a medical device company that develops, manufactures, and sells innovative insulin delivery systems, primarily through its Omnipod product platform, for people with insulin-dependent diabetes worldwide. The Omnipod offers a tub..
>Volltext.. |
| 12626.33 Mio. EUR |
| 12869.55 Mio. EUR |
| 2346.15 Mio. EUR |
| 508.53 Mio. EUR |
| 214.07 Mio. EUR |
| 3.04 EUR |
| 867.96 Mio. EUR |
| 620.37 Mio. EUR |
| 493.19 Mio. EUR |
| 1.05 |
| 15.23% |
| -47.93% |
| - |
| - |
| - |
| - |
| INSULET |
| 04.04.26 |